Bicara Therapeutics Inc. (BCAX)

NASDAQ

$17.36

$-0.13

(-0.74%)

Pre-Market

Bicara Therapeutics Inc. (BCAX) Live Price Chart

Last updated: ⁦2026-10-20 09:59:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bicara Therapeutics Inc. (BCAX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17.36, with a market capitalization of $1.11B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.70 to $30.99. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.11B
Open	$17.49
Day's High	$30.99
Day's Low	$7.80
Previous Close	$17.47
Volume	2.00
Average Volume	680.25K
P/E Ratio	--
52-Week High	$30.99
52-Week Low	$13.70
Dividend Yield	--
Earnings Date	--

Bicara Therapeutics Inc. (BCAX) Pre-Market Stock Price

Bicara Therapeutics Inc. (BCAX) is trading at $17.36 in pre-market trading as of 2026-10-20 09:28:00, down 0.62% ($0.11) from the previous close of $17.47

Pre-market trading shows how investors are pricing BCAX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Bicara Therapeutics Inc. (BCAX) 7-Day Stock Price Change

Over the past seven days, Bicara Therapeutics Inc. (BCAX) moved from $17.50 to $17.36, representing a decline of 0.79% ($0.14).

The stock traded between $16.60 and $17.99 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 916.93 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BCAX 52-Week Price Position

Position in Range: 21.2%

52W Low$13.70

52W High$30.99

BCAX is currently trading at $17.36, placing it 21.2% of the way from its 52-week low of $13.70 to its 52-week high of $30.99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bicara Therapeutics Inc. (BCAX)?

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.

Bicara Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	103
Exchange	NASDAQ
Company Website	https://www.bicara.com

How to Buy Bicara Therapeutics Inc. (BCAX) Stock on MEXC

Eligible investors can buy real shares of Bicara Therapeutics Inc. (BCAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BCAX and Place Your Order

Open the RealStocks trading page and search for BCAX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bicara Therapeutics Inc. (BCAX) stock price today?

Bicara Therapeutics Inc. (BCAX) is currently trading at $ 17.36, down 0.62% ($0.11) from the previous close of $ 17.47. Intraday prices update in real time during regular trading hours.

2.Is BCAX stock going up or down today?

As of 2026-10-20 09:28:00, BCAX is trading at $ 17.36, down 0.62% ($0.11) from its previous close of $ 17.47. The stock has traded between $ 7.80 and $ 30.99 during today’s regular session. Past price movements do not guarantee future results.

3.What is BCAX pre-market price?

As of 2026-10-20 09:28:00, BCAX is trading at $ 17.36 in pre-market trading, down 0.62% ($0.11) from the previous close of $ 17.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BCAX after-hours price?

As of 2026-10-20 09:28:00, BCAX is trading at $ 17.49 in after-hours trading, up 0.11% ($0.02) from the regular-session close of $ 17.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BCAX stock trading now?

BCAX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BCAX sit relative to its 52-week high and low?

Over the past 52 weeks, BCAX has traded between a low of $ 13.70 and a high of $ 30.99. At $ 17.36, the stock is positioned 21.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bicara Therapeutics Inc. in?

Bicara Therapeutics Inc. (BCAX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bicara Therapeutics Inc.'s market capitalization and where is it listed?

Bicara Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.11B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BCAX valued in terms of P/E ratio and EPS?

BCAX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bicara Therapeutics Inc. pay a dividend?

Bicara Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.